Bridgebio Pharma, Inc. · NASDAQ:BBIO

Kumar Neil exercised options for 71,215 Bridgebio Pharma, Inc. shares (Form 4)

Traded May 16, 2026 · Filed May 19, 2026

On May 16, 2026, Kumar Neil (Director, Chief Executive Officer) exercised options for 71,215 Bridgebio Pharma, Inc. shares, leaving 269,430 shares. Filed May 19, 2026 (Form 4).

Options exercised
71,215 shares
Holding after
269,430 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 16, 2026Common StockOption exercise33,544267,995Direct
May 16, 2026Common StockOption exercise19,599287,594Direct
May 16, 2026Common StockOption exercise11,553299,147Direct
May 16, 2026Common StockOption exercise6,519305,666Direct
May 16, 2026Common StockShares withheld for tax36,236US$66.13269,430Direct

Source

View original at SEC

Related